Topical tazarotene 0.05% versus glycolic acid 70% treatment in X-linked ichthyosis due to extensive deletion of the STS gene.
Cotellessa
Claudia
C
Cuevas-Covarrubias
Sergio A
SA
Valeri
Patrizia
P
Fargnoli
Maria Concetta
MC
Peris
Ketty
K
D000279:Administration, Cutaneous; D000328:Adult; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003937:Diagnosis, Differential; D004827:Epilepsy; D020022:Genetic Predisposition to Disease; D006016:Glycolates / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D016114:Ichthyosis, X-Linked / Q000175:diagnosis* / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D008297:Male; D009539:Nicotinic Acids / Q000008:administration & dosage / Q000627:therapeutic use*; D043266:Steryl-Sulfatase / Q000235:genetics*; D012176:Retinoids
D003879:Dermatologic Agents; D006016:Glycolates; D009539:Nicotinic Acids; D043266:Steryl-Sulfatase; C031149:glycolic acid; C086827:tazarotene; D012176:Retinoids